EGCG inhibited the auto-phosphorylation of c-Met/hepatocyte growth factor receptor (HGFR) at Tyr1234/1235 and modified the structure of lipid rafts in DU145 prostate cancer cells [121]. Here, MET is linked to prostate cancer.